Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: RaySearch Laboratories AB

Capitalization 6.53B 693M 605M 547M 523M 952M 64.06B 989M 2.59B 30.61B 2.6B 2.54B 111B P/E ratio 2025
34.3x
P/E ratio 2026 * 23.7x
Enterprise value 6.34B 672M 588M 531M 508M 924M 62.19B 960M 2.51B 29.71B 2.52B 2.47B 107B EV / Sales 2025
5.81x
EV / Sales 2026 * 4.54x
Free-Float
76%
Yield 2025 *
1.57%
Yield 2026 * 2.1%
1 day-0.42%
1 week-2.66%
Current month-0.52%
1 month+2.80%
3 months-16.77%
6 months-23.45%
Current year-16.40%
1 week 187
Extreme 187
198
1 month 175.2
Extreme 175.2
199
Current year 166.8
Extreme 166.8
228.5
1 year 166.8
Extreme 166.8
373.5
3 years 55.6
Extreme 55.6
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 31/12/1999
Director of Finance/CFO 48 26/01/2025
Chief Tech/Sci/R&D Officer 53 27/08/2015
Director TitleAgeSince
Director/Board Member 57 31/12/1999
Chairman 81 17/11/2016
Chairman 87 29/09/2022
Change 5d. change 1-year change 3-years change Capi.($)
-0.42%-2.66%-32.41%+137.36% 693M
-1.06%-8.50%-23.58%+3.35% 29.4B
-0.41%+0.23%-43.18%+118.50% 9.73B
+1.84%+9.43%-5.50%+49.20% 4.74B
+4.27%+49.22% - - 3.41B
-1.44%-10.84% - - 1.74B
-1.51%+16.68% - - 1.67B
-1.99%-16.71%+4.24%-36.34% 1.56B
-1.89%-5.11%-48.88% - 1.16B
-1.58%-1.97%-32.88%-49.18% 1.12B
Average -0.42%+2.94%-26.03%+37.15% 5.52B
Weighted average by Cap. -0.44%-1.14%-25.80%+31.07%

Financials

2025 2026 *
Net sales 1.32B 140M 122M 110M 106M 192M 12.93B 200M 523M 6.18B 525M 514M 22.31B 1.42B 150M 131M 119M 114M 207M 13.91B 215M 562M 6.65B 564M 553M 24.01B
Net income 223M 23.64M 20.66M 18.67M 17.86M 32.48M 2.19B 33.76M 88.37M 1.04B 88.7M 86.83M 3.77B 275M 29.15M 25.48M 23.02M 22.02M 40.05M 2.7B 41.64M 109M 1.29B 109M 107M 4.65B
Net Debt -192M -20.3M -17.74M -16.03M -15.33M -27.89M -1.88B -28.99M -75.89M -897M -76.17M -74.56M -3.24B -96M -10.18M -8.89M -8.04M -7.69M -13.98M -941M -14.53M -38.04M -450M -38.19M -37.38M -1.62B
Logo RaySearch Laboratories AB
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
458
Date Price Change Volume
13/03/26 190.60 kr -0.42% 92,558
12/03/26 191.40 kr +0.74% 263,104
11/03/26 190.00 kr -3.16% 262,287
10/03/26 196.20 kr +1.13% 113,444
09/03/26 194.00 kr -0.92% 179,234
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
190.60SEK
Average target price
330.00SEK
Spread / Average Target
+73.14%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW